Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Humana (HUM) Acquires Remaining Shares at Kindred at Home
by Zacks Equity Research
Humana (HUM) closes its Kindred at Home buyout to bolster its home health and hospice business.
Magellan (MGLN) Unveils Program to Improve Members' Mental Health
by Zacks Equity Research
Magellan's (MGLN) unit - Magellan Healthcare - launched eMbolden program for offering improved behavioral health outcomes for employees and specific clients.
4 Health Insurance Companies Poised for Growth in 2H21
by Srijita Guha
Strategic initiatives, rising enrolment and strength in Medicaid business are expected to aid health insurance companies like CNC, ANTM, MOH and UNH in 2H21.
Here's Why You Should Invest in Encompass Health (EHC) Now
by Zacks Equity Research
Encompass Health (EHC) is riding on top-line growth, higher patient volumes, continuous facility expansions and reducing debt levels.
Is Anthem (ANTM) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Select Medical (SEM) Q2 Earnings Beat, Raises '21 EPS View
by Zacks Equity Research
Select Medical's (SEM) second-quarter results reflect strong top-line growth, higher admissions and increased patient visits, partly offset by elevated costs.
Cigna (CI) Q2 Earnings Beat on Revenue Growth But Shares Fall
by Zacks Equity Research
Cigna's (CI) better-than-expected Q2 earnings benefit from better revenues, partly offset by higher medical cost.
Acadia Healthcare (ACHC) Beats on Q2 Earnings, Ups '21 EPS View
by Zacks Equity Research
Acadia Healthcare's (ACHC) second-quarter results highlight rise in revenues, courtesy of increased volumes and facility expansions, partly offset by high costs.
What's in Store for Cigna's (CI) Earnings in Q2?
by Zacks Equity Research
Cigna's (CI) Q2 results are likely to reflect an increase in revenues but a decline in its bottom line.
Universal Health (UHS) Beats on Q2 Earnings, Ups '21 EPS View
by Zacks Equity Research
Universal Health's (UHS) second-quarter results reflect growing revenues attributable to strong segmental performances, partly offset by elevated expenses.
Zacks.com featured highlights include: Intuit, Deere & Co, Boyd Gaming, Anthem and Skyworks Solutions
by Zacks Equity Research
Zacks.com featured highlights include: Intuit, Deere & Co, Boyd Gaming, Anthem and Skyworks Solutions
Tenet Healthcare (THC) Beats on Q2 Earnings, Ups '21 EPS View
by Zacks Equity Research
Tenet Healthcare's (THC) second-quarter results gain on the back of higher revenues, and well-performing Hospital, Ambulatory and Conifer segments, partly offset by escalating costs.
5 Stocks With Solid Dividend Growth for Steady Income
by Sweta Killa
Intuit Inc. (INTU), Deere & Company (DE), Boyd Gaming (BYD) Anthem (ANTM) and Skyworks Solutions (SWKS) are some solid dividend growth picks for your portfolio.
Anthem's (ANTM) Q2 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
Anthem's (ANTM) Q2 earnings gain from better revenues and growth in Medicaid and Medicare business lines.
Anthem (ANTM) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Anthem (ANTM) delivered earnings and revenue surprises of 10.88% and 0.38%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Anthem (ANTM) This Earnings Season?
by Zacks Equity Research
Anthem (ANTM) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Are Investors Undervaluing Anthem (ANTM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is a Beat in the Cards for Anthem (ANTM) in Q2 Earnings?
by Zacks Equity Research
Anthem's (ANTM) second-quarter results are likely to benefit on the back of higher premiums coupled with growing Medicaid and Medicare membership, partly offset by escalating costs.
UnitedHealth (UNH) Beats on Q2 Earnings, Hikes '21 EPS View
by Zacks Equity Research
UnitedHealth Group's (UNH) second-quarter 2021 results reflect improving revenues resulting in top-line growth at both the business units, partly offset by higher costs.
Anthem (ANTM) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Anthem (ANTM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Should You Add Anthem (ANTM) Stock to Your Portfolio?
by Zacks Equity Research
Aided by high revenues and strong Medicaid and Medicare businesses, Anthem (ANTM) holds enough potential to reap benefits for investors.
UnitedHealth (UNH) to Post Q2 Earnings: What's in the Offing?
by Zacks Equity Research
UnitedHealth's (UNH) Q2 revenues are likely to have grown on higher membership. Nevertheless, COVID-related costs and steep expenses due to investment in growth and innovation might have hurt earnings.
3 Health Insurers Poised to Beat Earnings Estimates in Q2
by Srijita Guha
Health insurers' second-quarter 2021 earnings results are likely to reflect higher premiums, partly offset by elevated operating costs.
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Anthem (ANTM) vs. Humana (HUM): Which is Better-Positioned?
by Zacks Equity Research
Anthem (ANTM) and Humana (HUM) are poised to grow in the thriving insurance brokerage space. Based on certain yardsticks, we try to find out which stock is better than the other.